Pfizer, BioNTech's mRNA flu vaccine starts phase 3 testing The first patients have been dosed in a phase 3 trial of an mRNA-based seasonal influenza vaccine developed by Pfizer and BioNTech, which may ...
The morning saw a very eager, disciplined, skillful fleet of Etchells sailors set out of Royal Freshwater Bay Yacht Club under a crisp sun and gentle easterly.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results